v3.26.1
STOCKHOLDERS’ EQUITY (Tables)
12 Months Ended
Dec. 31, 2025
Equity [Abstract]  
SCHEDULE OF WARRANT ACTIVITY

A summary of the warrant activity during the year ended December 31, 2025 is presented below:

  

           Weighted 
       Weighted   Average 
       Average   Remaining 
   Number of   Exercise   Life 
   Warrants   Price   In Years 
Outstanding, January 1, 2025   3,951,634   $5.22      
Granted   543,654    2.75      
Expired   (250)   60.00      
Outstanding, December 31, 2025   4,495,038   $4.94    2.60 
                
Exercisable, December 31, 2025   4,495,038   $4.94    2.60 
SCHEDULE OF STOCK WARRANTS

The following table presents information related to Common Stock warrants at December 31, 2025:

 

Warrants Outstanding   Warrants Exercisable 
        Weighted     
    Outstanding   Average   Exercisable 
Exercise   Number of   Remaining Life   Number of 
Price   Warrants   In Years   Warrants 
              
$2.43    2,513,686    3.1    2,513,686 
$2.75    543,654    4.8    543,654 
$2.92    51,370    1.9    51,370 
$10.00    1,150,358    0.9    1,150,358 
$12.50    235,970    0.9    235,970 
      4,495,038         4,495,038 
SCHEDULE OF STOCK OPTION GRANTED ASSUMPTIONS

In applying the Black-Scholes option pricing model to warrants granted, the Company used the following assumptions:

 

   October 8, 2025 
Risk free interest rate   3.72% 
Expected term (years)   5.00 
Expected volatility   95.36% 
Expected dividends   0.00%
SCHEDULE OF STOCK OPTION ACTIVITY

A summary of the option activity during the year ended December 31, 2025 is presented below:

 

           Weighted     
       Weighted   Average     
       Average   Remaining     
   Number of   Exercise   Life   Intrinsic 
   Options   Price   In Years   Value 
Outstanding, January 1, 2025   3,263,467   $2.63           
Granted   2,202,908    2.44           
Exercised   (29,249)   1.45           
Forfeited   (170,526)   2.20           
Outstanding, December 31, 2025   5,266,600   $2.57    7.5   $- 
                     
Exercisable, December 31, 2025   3,993,082   $2.69    7.1   $- 
SCHEDULE OF INFORMATION RELATED TO STOCK OPTIONS

The following table presents information related to stock options at December 31, 2025:

 

Options Outstanding   Options Exercisable 
        Weighted     
    Outstanding   Average   Exercisable 
Exercise   Number of   Remaining Life   Number of 
Price   Options   In Years   Options 
              
$1.45    1,705,824    7.1    1,414,156 
$1.62    25,000    9.8    12,500 
$1.78    25,000    9.4    12,500 
$2.46    2,141,129    9.1    1,184,279 
$2.91    565,049    5.7    565,049 
$5.08    804,598    4.9    804,598 
      5,266,600         3,993,082 
SCHEDULE OF STOCK OPTION GRANTED ASSUMPTIONS

In applying the Black-Scholes option pricing model to stock options granted, the Company used the following assumptions:

 

   For the Years Ended 
   December 31, 
   2025   2024 
Risk free interest rate   3.68 - 4.40%    4.14 - 4.30% 
Expected term (years)   5.27 - 5.38    2.77 - 5.38 
Expected volatility   95.96 - 99.32%    101 - 102% 
Expected dividends   0.00%    0.00%
SCHEDULE OF STOCK OPTION EXPENSE

The following table presents information related to stock-based compensation expense:

 

                 
   For the Years Ended   Unrecognized at  

Weighted Average Remaining

Amortization

 
   December 31,   December 31,   Period 
   2025   2024   2025   (Years) 
Research and development  $1,524,053   $1,358,204           
General and administrative   1,801,573    1,454,362           
Total  $3,325,626   $2,812,566   $1,492,747    1.65